Literature DB >> 11867605

Photodynamic effects on choroidal neovascularization and physiological choroid.

Ursula Schmidt-Erfurth1, Stephan Michels, Irene Barbazetto, Horst Laqua.   

Abstract

PURPOSE: To evaluate the effect of photodynamic therapy (PDT) on perfusion and vascular integrity of choroidal neovascularization (CNV) and collateral physiological choroid.
METHODS: In a prospective clinical trial, patients with subfoveal CNV were treated with PDT and verteporfin. Indocyanine green angiography (ICG-A), using a confocal laser scanning system with tomographic sections, was performed continuously 1 week before and 1, 4, and 12 weeks after and a mean long-term follow-up of 16.5 months after the final PDT. Vascular changes were localized tomographically and quantified on the level of the CNV and collateral choroid according to early lesion size, late hyperfluorescence, and persistence or recurrence. Data were analyzed separately from 38 eyes in a single- and 12 eyes in a multiple-treatment regimen.
RESULTS: CNV lesions were significantly reduced in size and late hyperfluorescence. However, 54% of lesions primarily demonstrated persistence, typically of the choroidal feeding complex, which was only detectable by ICG-A. Regrowth from the feeding vessel occurred regularly, but did not reach baseline dimensions. Collateral choroid exposed to photoactivation exhibited choriocapillary occlusion. Progressive recanalization was documented within 4 to 12 weeks after both single and multiple PDT. Residual changes in the choroidal filling pattern often persisted during long-term follow-up.
CONCLUSIONS: Tomographic ICG-A after PDT reveals persistence of CNV and/or the feeder vessel and a reduction in perfusion within the entire photosensitized area, including the surrounding choroid. Repair mechanisms occur slowly in neovascular and normal choroidal structures.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11867605

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  63 in total

1.  Early neovascular bridging after photodynamic therapy of myopic choroidal neovascularization.

Authors:  Paolo Lanzetta; Maurizio Battaglia Parodi; Massimo Ambesi-Impiombato; Giuseppe Ravalico; Francesco Bandello
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-06-22       Impact factor: 3.117

2.  Optical coherence tomography guided retreatment of photodynamic therapy.

Authors:  I Krebs; S Binder; U Stolba; K Schmid; C Glittenberg; W Brannath; A Goll
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

3.  Three-dimensional imaging of pigment epithelial detachment in age-related macular degeneration using optical coherence tomography, retinal thickness analysis and topographic angiography.

Authors:  Christian Ahlers; Stephan Michels; Arne Beckendorf; Reginald Birngruber; Ursula Schmidt-Erfurth
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-09-15       Impact factor: 3.117

4.  Optical coherence tomography to monitor photodynamic therapy in pathological myopia.

Authors:  A García-Layana; A Salinas-Alamán; M J Maldonado; C Sainz-Gómez; A Fernández-Hortelano
Journal:  Br J Ophthalmol       Date:  2006-02-07       Impact factor: 4.638

5.  Dynamics of retinal function after multiple photodynamic therapies in age-related macular degeneration: a report of cases.

Authors:  Beatrix Feigl; Brian Brown; Jan Lovie-Kitchin; Lawrence Lee
Journal:  Doc Ophthalmol       Date:  2006-03-06       Impact factor: 2.379

6.  Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy.

Authors:  R Uetani; Y Ito; K Oiwa; K Ishikawa; H Terasaki
Journal:  Eye (Lond)       Date:  2012-05       Impact factor: 3.775

7.  Enlargement of the hypofluorescent post photodynamic therapy treatment spot after a combination of photodynamic therapy with an intravitreal injection of bevacizumab for retinal angiomatous proliferation.

Authors:  Alexandros A Rouvas; Thanos D Papakostas; Ioannis D Ladas; Ioannis Vergados
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-10-24       Impact factor: 3.117

8.  Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level.

Authors:  W-M Chan; D S C Lam; T Y Y Lai; B S M Tam; D T L Liu; C K M Chan
Journal:  Br J Ophthalmol       Date:  2003-12       Impact factor: 4.638

9.  Photodynamic therapy of choroidal neovascularization with enlargement of the spot size to include the feeding complex.

Authors:  Ilias Georgalas; Alexandros A Rouvas; Dimitrios A Karagiannis; Athanasios I Kotsolis; Ioannis D Ladas
Journal:  Clin Ophthalmol       Date:  2009-06-02

10.  Indocyanine green angiographic features of myopic subfoveal choroidal neovascularization as a prognostic factor after photodynamic therapy.

Authors:  Suk Ho Byeon; Oh Woong Kwon; Sung Chul Lee; Sung Soo Kim; Hyoung Jun Koh
Journal:  Korean J Ophthalmol       Date:  2006-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.